BCHE and Alzheimer disease: In an attempt to improve the delivery and bioavailability of AD drugs to the brain, rivastigmine and tacrine, both cholinesterase inhibitors, were bonded to poly(n-butyl cyanoacrylate) (PPBCA) NPs alone and also in combination with the NPs coated with polysorbate 80, a non-ionic surfactant.